Valneva SE (VALN) Asset Utilization Ratio (2022 - 2026)

Valneva SE (VALN) posted quarterly Asset Utilization Ratio of 0.36 for Q1 2026, down 1.07% year-on-year from 0.37 in Q1 2025, and down 2.87% on a QoQ basis from 0.37 in Q4 2025.

Valneva SE (VALN) Asset Utilization Ratio (2022 - 2026) Analysis & Trends

Valneva SE (VALN) has reported Asset Utilization Ratio for 5 consecutive years, with 0.36 the latest figure, recorded in Q1 2026.

  • Quarterly Asset Utilization Ratio fell 1.07% year-over-year to 0.36 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.36 (down 1.07% YoY) and the FY2025 annual result came in at 0.35, up 3.28% from the prior year.
  • Asset Utilization Ratio eased to 0.36 in Q1 2026 per VALN's latest filing, from 0.37 in the prior quarter.
  • Over the last five years, Asset Utilization Ratio for VALN reached as high as 0.74 in Q3 2022 and fell as low as 0.31 in Q2 2024.
  • A 5-year average of 0.43 and a median of 0.37 in 2025 frame the typical range for Asset Utilization Ratio.
  • Annual changes were most pronounced in 2023 — Asset Utilization Ratio jumped 41.64% — and 2024, when it slumped 48.46%.
  • Year by year, Asset Utilization Ratio stood at 0.55 in 2022, then plunged by 42.76% to 0.31 in 2023, then increased by 2.47% to 0.32 in 2024, then grew by 16.05% to 0.37 in 2025, then declined by 2.87% to 0.36 in 2026.
  • According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.36, 0.37, and 0.37 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 0.69
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 0.47
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 0.37
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Valneva SE 803.90 Mn 680.66 Mn 5.38 Mn 0.36

Historic Data

Download Data
DateValue
Mar 31, 2026 0.36
Dec 31, 2025 0.37
Sep 30, 2025 0.37
Jun 30, 2025 0.40
Mar 31, 2025 0.37
Dec 31, 2024 0.32
Sep 30, 2024 0.31
Jun 30, 2024 0.31
Mar 31, 2024 0.32
Dec 31, 2023 0.31
Sep 30, 2023 0.42
Jun 30, 2023 0.60
Mar 31, 2023 0.62
Dec 31, 2022 0.55
Sep 30, 2022 0.74
Jun 30, 2022 0.52
Mar 31, 2022 0.43